- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 31, 2025 | 53.38M sh |
| Short Term Investments | Q1 2025 · Dec 28, 2024 | $260M |
| Short Term Investments | Q1 2025 · Sep 28, 2024 | $350M |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $278.33M |
| Cash And Equivalents | Q1 2025 · Sep 28, 2024 | $227.15M |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $169.15M |
| Current Liabilities | Q1 2025 · Sep 28, 2024 | $183.79M |
| Total Liabilities | Q1 2025 · Dec 28, 2024 | $278.7M |
| Total Liabilities | Q1 2025 · Sep 28, 2024 | $296.15M |
| Current Assets | Q1 2025 · Dec 28, 2024 | $1.01B |
| Current Assets | Q1 2025 · Sep 28, 2024 | $994.95M |
| Total Assets | Q1 2025 · Dec 28, 2024 | $1.25B |
| Total Assets | Q1 2025 · Sep 28, 2024 | $1.24B |
| Shares Diluted | Q1 2025 · Dec 30, 2023 | 57.02M sh |
| Stock Repurchased | Q1 2025 · Dec 30, 2023 | $27.24M |
| Capex | Q1 2025 · Dec 30, 2023 | $4.43M |
| Operating Cash Flow | Q1 2025 · Dec 30, 2023 | −$7.33M |
| Stockholders Equity | Q1 2025 · Dec 30, 2023 | $1.16B |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $1.17B |
| Eps Diluted | Q1 2025 · Dec 30, 2023 | $0.16 |
| Eps Basic | Q1 2025 · Dec 30, 2023 | $0.16 |
| Sga Expense | Q1 2025 · Dec 30, 2023 | $41.39M |
| Rd Expense | Q1 2025 · Dec 30, 2023 | $36.81M |
| Net Income | Q1 2025 · Dec 30, 2023 | $9.29M |
| Operating Income | Q1 2025 · Dec 30, 2023 | $1.69M |
| Gross Profit | Q1 2025 · Dec 30, 2023 | $79.9M |
| Cost Of Revenue | Q1 2025 · Dec 30, 2023 | $91.29M |
| Revenue | Q1 2025 · Dec 30, 2023 | $171.19M |